| Utility: Activatable cytokine constructs and related compositions and methods Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 | 9 Apr 2021 | 21 Jun 2022 |
| Utility: Anti-CD40 antibodies and uses thereof Filling date: 8 Sep 2025 Issue date: 19 Apr 2022 | 27 Dec 2018 | 19 Apr 2022 |
| Utility: Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 | 13 Nov 2018 | 8 Mar 2022 |
| Utility: Anti-CD166 antibodies and uses thereof Filling date: 8 Sep 2025 Issue date: 11 Jan 2022 | 13 Jul 2018 | 11 Jan 2022 |
| Utility: Protease-resistant systems for polypeptide display and methods of making and using thereof Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 | 2 Mar 2020 | 14 Dec 2021 |
| Utility: Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies Filling date: 8 Sep 2025 Issue date: 23 Nov 2021 | 12 Dec 2019 | 23 Nov 2021 |
| Utility: Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 | 31 May 2019 | 16 Nov 2021 |
| Utility: Activatable anti-PDL1 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 9 Nov 2021 | 31 May 2018 | 9 Nov 2021 |
| Utility: Multispecific antibodies, multispecific activatable antibodies and methods of using the same Filling date: 8 Sep 2025 Issue date: 2 Nov 2021 | 25 Jul 2014 | 2 Nov 2021 |
| Utility: Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof Filling date: 8 Sep 2025 Issue date: 29 Jun 2021 | 20 Jan 2016 | 29 Jun 2021 |
| Utility: Compositions and methods for detecting protease activity in biological systems Filling date: 8 Sep 2025 Issue date: 15 Jun 2021 | 15 Feb 2019 | 15 Jun 2021 |
| Utility: Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 | 15 Oct 2018 | 8 Jun 2021 |
| Utility: Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 | 13 Aug 2018 | 8 Jun 2021 |
| Utility: Protease-resistant systems for polypeptide display and methods of making and using thereof Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 28 Mar 2016 | 16 Mar 2021 |
| Utility: Activatable antibodies having non-binding steric moieties and methods of using the same Filling date: 8 Sep 2025 Issue date: 19 Jan 2021 | 13 Dec 2017 | 19 Jan 2021 |
| Utility: Methods of treatment using activatable anti-EGFR antibodies Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 23 Aug 2018 | 29 Dec 2020 |
| Utility: Therapeutic antibodies Filling date: 8 Sep 2025 Issue date: 13 Oct 2020 | 18 Dec 2015 | 13 Oct 2020 |
| Utility: Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 | 4 May 2016 | 18 Aug 2020 |
| Utility: Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof Filling date: 8 Sep 2025 Issue date: 14 Jul 2020 | 19 Jan 2018 | 14 Jul 2020 |
| Utility: Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 | 31 May 2019 | 2 Jun 2020 |
| Utility: Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 | 24 Jul 2015 | 2 Jun 2020 |
| Utility: Activatable antibodies that bind interleukin-6 receptor and methods of use thereof Filling date: 8 Sep 2025 Issue date: 7 Apr 2020 | 21 Sep 2016 | 7 Apr 2020 |
| Utility: Antibodies that bind activatable antibodies and methods of use thereof Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 | 26 Jul 2017 | 25 Feb 2020 |
| Utility: Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 | 19 Dec 2016 | 14 Jan 2020 |
| Utility: Cleavage-activatable interferon-alpha proprotein Filling date: 8 Sep 2025 Issue date: 24 Dec 2019 | 8 May 2017 | 24 Dec 2019 |
| Utility: Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 24 Dec 2019 | 13 Jul 2016 | 24 Dec 2019 |
